Many biotech entrepreneurs dread the possibility of investors taking control in a situation that resembles a hostile takeover. But it needn't be that way.| Labiotech.eu
Alan Levy shares his experience on how to make the relationship between the board and the CEO of a life sciences company work.| Labiotech.eu